fluconazole has been researched along with Zygomycosis in 14 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Zygomycosis: Infection in humans and animals caused by fungi in the class Zygomycetes. It includes MUCORMYCOSIS and entomophthoramycosis. The latter is a tropical infection of subcutaneous tissue or paranasal sinuses caused by fungi in the order Entomophthorales. Phycomycosis, closely related to zygomycosis, describes infection with members of Phycomycetes, an obsolete classification.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Terms such as micafungin, aspergillosis, zygomycosis, invasive fungal infections, emerging fungal infections, antifungal treatment or therapy, antifungal prophylaxis, empiric or pre-emptive therapy were crossed." | 8.85 | [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi]. ( Salavert-Lletí, M; Zaragoza-Crespo, R, 2009) |
| "We report a case of breakthrough invasive zygomycosis in a stem cell transplant recipient who was receiving caspofungin for treatment of a breakthrough Candida krusei fungemia that occurred during fluconazole prophylaxis." | 7.73 | Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation. ( Barberi, W; Foà, R; Girmenia, C; Iori, AP; Martino, P; Micozzi, A; Moleti, ML, 2005) |
| " Terms such as micafungin, aspergillosis, zygomycosis, invasive fungal infections, emerging fungal infections, antifungal treatment or therapy, antifungal prophylaxis, empiric or pre-emptive therapy were crossed." | 4.85 | [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi]. ( Salavert-Lletí, M; Zaragoza-Crespo, R, 2009) |
| "We report a case of breakthrough invasive zygomycosis in a stem cell transplant recipient who was receiving caspofungin for treatment of a breakthrough Candida krusei fungemia that occurred during fluconazole prophylaxis." | 3.73 | Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation. ( Barberi, W; Foà, R; Girmenia, C; Iori, AP; Martino, P; Micozzi, A; Moleti, ML, 2005) |
| "Fungemia is a serious problem within neonatal intensive care units around the world." | 2.50 | Fungal prophylaxis in neonates: a review article. ( Bradshaw, WT; Lollis, TR, 2014) |
| "Zygomycosis is an infection caused by opportunistic fungi of the Zygomycetes class, specifically those from the Mucorales and Entomophthorales orders." | 1.36 | Meningoencephalitis caused by a zygomycete fungus (Basidiobolus) associated with septic shock in an immunocompetent patient: 1-year follow-up after treatment. ( Alkmim-Teixeira, GC; Auxiliadora-Martins, M; Basile-Filho, A; Bellissimo-Rodrigues, F; Carlotti, CG; Machado-Viana, J; Martins-Filho, OA; Nicolini, EA, 2010) |
| "Fluconazole has proven efficacy in prophylaxis, treatment and suppressive therapy of both systemic and superficial fungal infections, especially in candidosis and cryptococcosis." | 1.30 | Therapeutic experience with fluconazole in the treatment of fungal infections in diabetic patients. ( Penk, A; Pittrow, L, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lollis, TR | 1 |
| Bradshaw, WT | 1 |
| Kumaravel, S | 1 |
| Bharath, K | 1 |
| Rajesh, NG | 1 |
| Singh, R | 1 |
| Kar, R | 1 |
| Bamba, S | 1 |
| Konsegré, V | 1 |
| Zida, A | 1 |
| Sangaré, I | 1 |
| Cissé, M | 1 |
| Beogo, R | 1 |
| Diallo, B | 1 |
| Andonaba, JB | 1 |
| Guiguemdé, RT | 1 |
| Salavert-Lletí, M | 1 |
| Zaragoza-Crespo, R | 1 |
| Bhat, RM | 1 |
| Srinivas, M | 1 |
| Sequeira, F | 1 |
| Sukumar, D | 1 |
| Swethadri, GK | 1 |
| Auxiliadora-Martins, M | 1 |
| Alkmim-Teixeira, GC | 1 |
| Machado-Viana, J | 1 |
| Nicolini, EA | 1 |
| Martins-Filho, OA | 1 |
| Bellissimo-Rodrigues, F | 1 |
| Carlotti, CG | 1 |
| Basile-Filho, A | 1 |
| Gordon, CL | 1 |
| Whiting, S | 1 |
| Haran, G | 1 |
| Ward, A | 1 |
| Coleman, M | 1 |
| Baird, R | 1 |
| Jeremiah, CJ | 1 |
| Mileva, M | 1 |
| Davis, JS | 1 |
| Warren, LJ | 1 |
| Ellis, DH | 1 |
| Currie, BJ | 1 |
| Girmenia, C | 1 |
| Moleti, ML | 1 |
| Micozzi, A | 1 |
| Iori, AP | 1 |
| Barberi, W | 1 |
| Foà, R | 1 |
| Martino, P | 1 |
| Receveur, MC | 1 |
| Roussin, C | 1 |
| Mienniel, B | 1 |
| Gasnier, O | 1 |
| Rivière, JP | 1 |
| Malvy, D | 1 |
| Lortholary, O | 1 |
| Bonifaz, A | 1 |
| Macias, B | 1 |
| Paredes-Farrera, F | 1 |
| Arias, P | 1 |
| Ponce, RM | 1 |
| Araiza, J | 1 |
| Barro-Traoré, F | 1 |
| Ouédraogo, D | 1 |
| Konsem, T | 1 |
| Ouédraogo, MS | 1 |
| Lompo-Goumbri, O | 1 |
| Sanou, A | 1 |
| Ouoba, K | 1 |
| Traoré, A | 1 |
| de Pauw, BE | 1 |
| Meunier, F | 1 |
| Penk, A | 1 |
| Pittrow, L | 1 |
| Kami, M | 1 |
| Machida, U | 1 |
| Okuzumi, K | 1 |
| Matsumura, T | 1 |
| Mori Si, S | 1 |
| Hori, A | 1 |
| Kashima, T | 1 |
| Kanda, Y | 1 |
| Takaue, Y | 1 |
| Sakamaki, H | 1 |
| Hirai, H | 1 |
| Yoneyama, A | 1 |
| Mutou, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| ANTIVORIFUNGOL:Strategy of Antifungal Use in Oncohematological Neutropenic Patients. Use of Voriconazole as Early Treatment.[NCT00386802] | Phase 4 | 115 participants (Anticipated) | Interventional | 2006-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for fluconazole and Zygomycosis
| Article | Year |
|---|---|
Fungal prophylaxis in neonates: a review article.
Topics: Administration, Intravenous; Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; | 2014 |
Delay and misdiagnosis of basidiobolomycosis in tropical South India: case series and review of the literature.
Topics: Antifungal Agents; Child; Child, Preschool; Diagnosis, Differential; Diagnostic Errors; Entomophthor | 2016 |
[Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
Topics: Adult; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Child; Clinical Trials as Topic; Doub | 2009 |
The challenge of invasive fungal infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis | 1999 |
10 other studies available for fluconazole and Zygomycosis
| Article | Year |
|---|---|
[A case of rhinofacial entomophthoromycosis in Soudano-Sahelian tropical climate in Burkina Faso].
Topics: Aged; Burkina Faso; Conidiobolus; Facial Dermatoses; Female; Fluconazole; Humans; Mucormycosis; Nose | 2017 |
Rhinoentomophthoromycosis with mutilation.
Topics: Anti-Bacterial Agents; Antifungal Agents; Dermatomycoses; Disease Progression; Entomophthora; Facial | 2010 |
Meningoencephalitis caused by a zygomycete fungus (Basidiobolus) associated with septic shock in an immunocompetent patient: 1-year follow-up after treatment.
Topics: Aged; Amphotericin B; Antifungal Agents; Entomophthorales; Fluconazole; Follow-Up Studies; Humans; I | 2010 |
Entomophthoromycosis caused by Basidiobolus ranarum in tropical northern Australia.
Topics: Antifungal Agents; Australia; Child, Preschool; Drug Therapy, Combination; Entomophthorales; Flucona | 2012 |
Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
Topics: Adolescent; Anemia, Aplastic; Antifungal Agents; Candida; Candidiasis; Caspofungin; Chemoprevention; | 2005 |
[Rhinofacial entomophthoromycosis. About two new cases in Mayotte].
Topics: Adult; Amphotericin B; Antifungal Agents; Conidiobolus; Face; Female; Fluconazole; Humans; Itraconaz | 2005 |
Palatal zygomycosis: experience of 21 cases.
Topics: Absidia; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Child; Diabetic | 2008 |
[Conidiobolomycosis, a rare fungal tumor: a case report in Ouagadougou, Burkina Faso].
Topics: Adolescent; Antifungal Agents; Burkina Faso; Conidiobolus; Dermatomycoses; Eyelid Diseases; Facial D | 2008 |
Therapeutic experience with fluconazole in the treatment of fungal infections in diabetic patients.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Oral; Candidiasis, Vulvovaginal; Diabetes Complic | 1999 |
Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Autopsy; Candidiasis; | 2002 |